Outcomes of Pediatric Liver Transplantation in Japan: A Report from the Registry of the Japanese Liver Transplantation Society

Supplemental Digital Content is available in the text. Background. The Japanese Liver Transplantation Society (JLTS), a cooperative research consortium, was established in 1980 to characterize and follow trends in patient characteristics and graft survival among all liver transplant patients in Japan. This study analyzed factors that may affect the current outcomes of pediatric patients who undergo liver transplantation (LT) by evaluating one of the largest pediatric LT cohorts in the world. Methods. Between November 1989 and December 2018, 3347 pediatric patients underwent LT in Japan. The survival outcomes of each donor and recipient variant were evaluated. Results. The procedures performed during the study period included living donor LT (LDLT; n = 3271), deceased donor LT (DDLT; n = 69), and domino LT (n = 7). There were 1510 male (45.1%) and 1837 female (54.9%) recipients with a median age of 1.7 y (range: 9 d to 17.9 y). The graft survival rates at 1, 10, 20, and 30 y were 88.9%, 82.2%, 77.1%, and 75.4%, respectively. Donor age, donor BMI, blood type incompatibility, recipient age, etiology of liver disease, transplant type, center experience, and transplant era were found to be significant predictors of overall graft survival. LDLT is a major treatment modality for the end-stage liver disease in children; DDLT and domino LT were applied as alternative treatments for LDLT in patients with specific pediatric liver diseases that are considered to have a poor prognosis following LDLT. Conclusions. Satisfactory long-term pediatric patient survival outcomes were achieved in the JLTS series, and we should continue to promote the deceased donor organ transplantation program in Japan.

[1]  Ruth R. Montgomery,et al.  Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. , 2012, Immunity.

[2]  P. Rosenthal,et al.  Trends over a decade of pediatric liver transplantation in the United States , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[3]  H. Amemiya Current status of organ transplantation in Japan. , 1999, Transplantation proceedings.

[4]  Christopher E. Smith United States , 1985, The Lancet.

[5]  J. Lerut,et al.  Impact of innovative techniques on the waiting list and results in pediatric liver transplantation. , 1993, Transplantation.

[6]  Y. Yamaoka,et al.  The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation. , 1996, Transplantation.

[7]  K. Umeshita,et al.  Optimal dosage regimen for rituximab in ABO‐incompatible living donor liver transplantation , 2017, Journal of hepato-biliary-pancreatic sciences.

[8]  H. Ohdan,et al.  Current status of liver transplantation across ABO blood-type barrier. , 2008, Journal of hepato-biliary-pancreatic surgery.

[9]  G. Mazariegos,et al.  A Multivariate Analysis of Pre-, Peri-, and Post-Transplant Factors Affecting Outcome After Pediatric Liver Transplantation , 2011, Annals of surgery.

[10]  Johnny C. Hong,et al.  Predictors of outcomes after pediatric liver transplantation: an analysis of more than 800 cases performed at a single institution. , 2007, Journal of the American College of Surgeons.

[11]  Ofer Levy,et al.  Innate immunity of the newborn: basic mechanisms and clinical correlates , 2007, Nature Reviews Immunology.

[12]  H. Eguchi,et al.  Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society , 2019, Hepatology research : the official journal of the Japan Society of Hepatology.

[13]  Y. Kokubo,et al.  For making a declaration of countermeasures against the falling birth rate from the Japanese Society for Hygiene: summary of discussion in the working group on academic research strategy against an aging society with low birth rate , 2019, Environmental Health and Preventive Medicine.

[14]  M. Rela,et al.  Feasibility and Safety of Split‐Liver Transplantation in a Nascent Framework of Deceased Donation , 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[15]  J. Bragg-Gresham,et al.  Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  S. Kawasaki,et al.  Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

[17]  K. Umeshita,et al.  Long‐Term Outcomes of Pediatric Living Donor Liver Transplantation in Japan: An Analysis of More Than 2200 Cases Listed in the Registry of the Japanese Liver Transplantation Society , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[18]  M. Kasahara,et al.  Waiting list mortality for pediatric deceased donor liver transplantation in a Japanese living‐donor–dominant program , 2019, Pediatric transplantation.

[19]  E. Choe,et al.  Long-term Survival of 10,116 Korean Live Liver Donors , 2019, Annals of surgery.

[20]  N. Nagasue,et al.  Segmental (partial) liver transplantation from a living donor. , 1992, Transplantation proceedings.

[21]  S. Uemoto,et al.  Living donor liver transplantation for pediatric patients with metabolic disorders: The Japanese multicenter registry , 2014, Pediatric transplantation.

[22]  J. Hiatt,et al.  One Thousand Pediatric Liver Transplants During Thirty Years: Lessons Learned. , 2018, Journal of the American College of Surgeons.

[23]  D. Mirza,et al.  The UK DCD Risk Score: A new proposal to define futility in donation-after-circulatory-death liver transplantation. , 2017, Journal of hepatology.

[24]  H. Egawa Challenge to ABO blood type barrier in living donor liver transplantation. , 2020, Hepatobiliary & pancreatic diseases international : HBPD INT.

[25]  H. Shinohara,et al.  Living related liver transplantation across ABO blood groups. , 1994, Transplantation.

[26]  D. Segev,et al.  Loss of Pediatric Kidney Grafts During the “High–Risk Age Window”: Insights From Pediatric Liver and Simultaneous Liver–Kidney Recipients , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[27]  D. Segev,et al.  Fifteen‐Year Trends in Pediatric Liver Transplants: Split, Whole Deceased, and Living Donor Grafts , 2018, The Journal of pediatrics.

[28]  Jie Zheng,et al.  Across all solid organs, adolescent age recipients have worse transplant organ survival than younger age children: A US national registry analysis , 2015, Pediatric transplantation.

[29]  Hong-Jin Kim,et al.  Surgical techniques and innovations in living related liver transplantation. , 1993, Annals of surgery.

[30]  Shohei Matsuzaki,et al.  Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background , 2003, Journal of Gastroenterology.

[31]  S. Kawasaki,et al.  Donor hepatectomy for living related partial liver transplantation. , 1993, Surgery.